Search references for 2 METHYL-MDA. Phrases containing 2 METHYL-MDA
See searches and references containing 2 METHYL-MDA!2 METHYL-MDA
Chemical compound
2-Methyl-3,4-methylenedioxyamphetamine (2-methyl-MDA) is an entactogen-related drug of the amphetamine class. It acts as a selective serotonin releasing
2-Methyl-MDA
Chemical compound
5-Methyl-MDA, also known as 5-methyl-3,4-methylenedioxyamphetamine, is an entactogen and psychedelic designer drug of the amphetamine class. It is a ring-methylated
5-Methyl-MDA
Psychoactive drug, often called ecstasy
1993). "A novel metabolite of 3,4-methylenedioxyamphetamine (MDA): formation of 3-methyl-6,7-methylenedioxy-1,2,3,4-tetrahydroisoquinoline and its pharmacological
MDMA
Psychoactive drug
several-fold less potent than its analogues 2-methyl-MDA and 5-methyl-MDA, and approximately half as potent as MDA, 6-methyl-MDA is still significantly active. According
6-Methyl-MDA
Index of chemical compounds with the same name
Methyl-MDA, also known as methylmethylenedioxyamphetamine, may refer to: N-Methyl-MDA (MDMA) 2-Methyl-MDA 5-Methyl-MDA 6-Methyl-MDA This set index article
Methyl-MDA
Central nervous system stimulant
Netherlands: Harwood Academic Publishers. p. 2. ISBN 978-90-5702-081-0. Methamphetamine (INN: metamfetamine) is the N-methyl derivative of amphetamine. Unlike amfetamine
Methamphetamine
Central nervous system stimulant
as AMPH (table 2). Glennon RA, Yousif M, Patrick G (March 1988). "Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs". Pharmacol
Amphetamine
Entactogen, stimulant, and psychedelic drug of the amphetamine family
2-Benzo[1,3]dioxol-5-yl-1-methyl-ethylamine::2-Benzo[1,3]dioxol-5-yl-1-methyl-ethylamine::2-Benzo[1,3]dioxol-5-yl-1-methyl-ethylamine((R)-(-)-MDA)::3
3,4-Methylenedioxyamphetamine
Chemical compound
steps from 2-bromopropiophenone and ethanolamine. The intermediate alcohol 3-methyl-2-phenylmorpholin-2-ol (1) is converted to a fumarate salt (2) with fumaric
Phenmetrazine
Recreational drug
dissolved in glacial acetic acid to bromine, creating an oil fraction of 4'-methyl-2-bromopropiophenone. The oil fraction can then be dissolved in dichloromethane
Mephedrone
Trace amine
amphetamine [AMPH (11 & 12)], methylenedioxy methamphetamine [METH (13)] and N-methyl-4-phenylpyridinium (15) are all more potent inhibitors of VMAT2... Miller
Phenethylamine
Class of psychoactive drugs that produce empathic experiences
(MDxx) MDMA, MDA, MDEA, MDOH, MBDB, and methylone, the benzofurans 5-APB, 5-MAPB, 6-APB, and 6-MAPB, the cathinone mephedrone, the 2-aminoindane MDAI
Entactogen
Index of chemical compounds with the same molecular formula
(2,3-MDMA) 3,4-Methylenedioxyphentermine Methyl-MDA 2-Methyl-MDA 5-Methyl-MDA 6-Methyl-MDA Tolibut This set index page lists chemical structure
C11H15NO2
Psychedelic drug
DMT derivatives include 1-methyl-DMT, lespedamine (1-MeO-DMT), 2-methyl-DMT, 4-methyl-DMT, 4-MeO-DMT, 4-fluoro-DMT, 5-methyl-DMT, 5-ethyl-DMT, 5-TFM-DMT
Dimethyltryptamine
Chemical compound
5-MAPB, also known as 5-(N-methyl-2-aminopropyl)benzofuran, as well as by nicknames such as "MDMA 2.0" and "Gas Station Molly", is an entactogen of the
5-MAPB
Drug mixture used mainly to treat ADHD and narcolepsy
as AMPH (table 2). Glennon RA, Yousif M, Patrick G (March 1988). "Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs". Pharmacol
Adderall
Chemical compound found in some species of mushrooms
(metabotropic glutamate receptor 2) (Benneyworth et al., 2007), and selective antagonists of the NR2B subunit of NMDA (N-methyl-D-aspartate) receptors (Lambe
Psilocybin
Chemical compound
Phenethylamines: 2-Methyl-MDA pCPE 4-CAB 4-FA 4-FMA 4-HA 4-MTA 4-ME 5-APB 5-APBT 5-APDB 5-MAPB 5-Methyl-MDA 6-APB 6-APBT 6-APDB 6-MAPB 6-Methyl-MDA AEMMA Amiflamine
2C-B-BZP
d2-MDMA MMDA (5-methoxy-MDA) 5-Methyl-MDA[citation needed] Methylbenzodioxolylbutanamine (MBDB) Methylenedioxyamphetamine (MDA) Methylenedioxyethylamphetamine
List_of_entactogens
Stimulant and empathogenic drug
4-methylenedioxyamphetamines by gas chromatography-mass spectrometry". Forensic Toxicol. 26 (2): 45–51. doi:10.1007/s11419-008-0050-1. S2CID 2871089. Kikura-Hanajiri R,
Dimethylone
Drug that releases serotonin and dopamine in the brain
2024. "β-Oxo-5-fluoro-α-methyl-NMT". Isomer Design. 10 November 2024. Retrieved 11 November 2024. "1-(5-chloro-1H-indol-3-yl)-2-(methylamino)propan-1-one"
Serotonin–dopamine releasing agent
Serotonin–dopamine_releasing_agent
Chemical compound
patent 3415937, "The Suppression of Appetite with 1-(o-Chlorophenyl)-2-Methyl-2-Propylamine" Triggle DJ (1996). Dictionary of Pharmacological Agents
Clortermine
CNS stimulant and isomer of amphetamine
as AMPH (table 2). Glennon RA, Yousif M, Patrick G (March 1988). "Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs". Pharmacol
Dextroamphetamine
Pharmaceutical compound
Homo-MDA (HMDA), also known as α-methyl-γ-(3,4-methylenedioxyphenyl)propylamine, is a entactogen-like drug related to 3,4-methylenedioxyamphetamine (MDA)
Homo-MDA
Chemical compound
evaluation of ring-methylated derivatives of 3,4-(methylenedioxy)amphetamine (MDA)". Journal of Medicinal Chemistry. 41 (6): 1001–5. doi:10.1021/jm9705925
5-APDI
Psychoactive drug
dissolved in dichloromethane to bromine gives 3′,4′-methylenedioxy-2-bromobutyrophenone. This product was then dissolved in dichloromethane and
Butylone
Monoamine metabolism inhibitor
(para-chlorophenylalanine) Metirosine (α-methyl-para-tyrosine) Methyldopa (α-methyl-DOPA) α-Methyltryptophan 3,4-Dihydroxystyrene "alpha-methyl-L-phenylalanine". PubChem
Α-Methylphenylalanine
Chemical compound
preference for induction of norepinephrine release over dopamine. The 2,3-methyl and 4-methyl analogues show diminished activity as dopamine releasing agents with
Ortho-Methylphenylpiperazine
Chemical compound
covered by the Australian analogue act as an analogue of MDA "by the replacement of up to 2 carbocyclic or heterocyclic ring structures with different
6-(2-Aminopropyl)indole
Chemical compound
MBDB, also known as N-methyl-1,3-benzodioxolylbutanamine or as 3,4-methylenedioxy-N-methyl-α-ethylphenylethylamine, is an entactogen of the phenethylamine
MBDB
Stimulant drug of the amphetamine class
Higgs RA, Glennon RA (December 1990). "Stimulus properties of ring-methyl amphetamine analogs". Pharmacology, Biochemistry, and Behavior. 37 (4):
Ortetamine
Psychedelic drug
(4-chloro-2,5-DMPEA) 2C-D (4-methyl-2,5-DMPEA) 2C-E (4-ethyl-2,5-DMPEA) DOB (α-methyl-2C-B) DOM (α-methyl-2C-D) 4C-B (α-ethyl-2C-B) β-Methyl-2C-B (BMB) BOH-2C-B
2C-B
Pharmaceutical compound
Phenylbutenamine, or 4-phenylbut-3-en-2-amine, is a monoamine releasing agent (MRA) of the arylalkylamine family related to β-phenethylamine and amphetamine
Phenylbutenamine
Psychedelic and entactogen
N-hydroxy-MDA, is an entactogen, psychedelic, and stimulant of the phenethylamine, amphetamine, and MDxx families. It is the N-hydroxy homologue of MDA, and
3,4-Methylenedioxy-N-hydroxyamphetamine
3,4-Methylenedioxy-N-hydroxyamphetamine
Stimulant and entactogen drug of the amphetamine class
theorized that 4-methyl and β-keto substitutions on amphetamines may result in loss of activity at the vesicular monoamine transporter 2 (VMAT2), loss of
4-Methylmethamphetamine
Chemical compound
5-MAPDB, also known as 5-(2-(methylamino)propyl)-2,3-dihydrobenzofuran, is an entactogen of the dihydrobenzofuran family. It is structurally related to
5-MAPDB
Stimulant drug of the phenethylamine class
4-Methylphenylisobutylamine (4-MAB), also known as 4-methyl-α-ethylphenethylamine, is a stimulant drug of the phenethylamine, amphetamine, and phenylisobutylamine
4-Methylphenylisobutylamine
Pharmaceutical compound
Phenethylamines: 2-Methyl-MDA pCPE 4-CAB 4-FA 4-FMA 4-HA 4-MTA 4-ME 5-APB 5-APBT 5-APDB 5-MAPB 5-Methyl-MDA 6-APB 6-APBT 6-APDB 6-MAPB 6-Methyl-MDA AEMMA Amiflamine
Isocyclamine
Chemical compound
been studied to determine its pharmacological activity, though it is the N-methyl derivative of 6-APDB which is known to be a selective serotonin releaser
6-MAPDB
Chemical compound
Lophophine (MMDPEA) Amphetamines: 2-Methyl-MDA 3,4-MDA (tenamfetamine) 5-Methyl-MDA 6-Methyl-MDA d2-MDMA DFMDA EIDA Lys-MDA MDEA (MDE) MDMA (midomafetamine;
IBF5MAP
Pharmaceutical compound
4-Dimethylamylamine (1,4-DMAA), also known as 1,4-dimethylpentylamine or as 5-methylhexan-2-amine, is a stimulant drug of the alkylamine family related to methylhexanamine
1,4-Dimethylamylamine
Type of drug
(SNDRI). Examples of SNDRAs include specific amphetamines such as MDMA, MDA, 4-methylamphetamine, methamphetamine (in high doses), certain substituted
Serotonin–norepinephrine–dopamine releasing agent
Serotonin–norepinephrine–dopamine_releasing_agent
Chemical compound
epinephrine, corresponding to ~ 1/3 the potency of amphetamine. The β-methyl compound also had ~ 2 x the broncho-dilating power of amphetamine (as measured using
Β-Methylphenethylamine
Chemical compound
Phenethylamines: 2-Methyl-MDA pCPE 4-CAB 4-FA 4-FMA 4-HA 4-MTA 4-ME 5-APB 5-APBT 5-APDB 5-MAPB 5-Methyl-MDA 6-APB 6-APBT 6-APDB 6-MAPB 6-Methyl-MDA AEMMA Amiflamine
Flucetorex
Substituted cathinone designer drug
Shimshoni JA, Britzi M, Sobol E, Willenz U, Nutt D, Edery N (June 2015). "3-Methyl-methcathinone: Pharmacokinetic profile evaluation in pigs in relation to
3-Methylmethcathinone
Chemical compound
2-MAPB is a recreational designer drug with empathogenic effects. As with other related substituted benzofuran derivatives such as 6-APB and 5-MAPB, 2-MAPB
2-MAPB
Chemical compound
Substituted methylenedioxyphenethylamine 2,3-Methylenedioxyamphetamine (2,3-MDA) 1-Naphthylmethcathinone (AMAPN) Cody JT, Valtier S (2002). "Differentiation
2,3-Methylenedioxymethamphetamine
2,3-Methylenedioxymethamphetamine
Central nervous system stimulant prodrug
as AMPH (table 2). Glennon RA, Yousif M, Patrick G (March 1988). "Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs". Pharmacol
Lisdexamfetamine
Designer drug combination mimicking MDMA
of MDMA that have been developed, including a variety of analogues like MDA, MDEA, MBDB, MDAI, MMAI, methylone, mephedrone, and 5-MAPB among others,
Borax_combo
Class of chemical compounds
(MDA)". J Med Chem. 33 (2): 703–710. doi:10.1021/jm00164a037. PMID 1967651. Oberlender R, Nichols DE (December 1990). "(+)-N-methyl-1-(1
Substituted_2-aminoindane
Pharmaceutical compound
N-Methyl-1-(3,4-methylenedioxyphenyl)-1-ethanamine (MDM1EA), also known as α,N-dimethyl-3,4-methylenedioxybenzylamine (α,N-DMMDBA) or as α,N-dimethylpiperonylamine
MDM1EA
MDMA metabolite
is substantially less potent than MDMA or 3,4-methylenedioxyamphetamine (MDA) as a monoamine releasing agent in vitro. Nonetheless, HMA has been found
4-Hydroxy-3-methoxyamphetamine
4-Hydroxy-3-methoxyamphetamine
Chemical compound
Lophophine (MMDPEA) Amphetamines: 2-Methyl-MDA 3,4-MDA (tenamfetamine) 5-Methyl-MDA 6-Methyl-MDA d2-MDMA DFMDA EIDA Lys-MDA MDEA (MDE) MDMA (midomafetamine;
5-MAPDI
Pharmaceutical compound
compound as a MAOI-A. Thus, the N-methyl derivatives of AMPH, MTA, p-methoxyAMPH (PMA), and 3,4-methylenedioxyAMPH (MDA)— i.e. methamphetamine, NMMTA, PMMA
4-Methylthiomethamphetamine
Stimulant designer drug
derivatives, 5-APB and 6-APB, mimic the effects of 3,4-methylenedioxyamphetamine (MDA) on monoamine transmission in male rats". Psychopharmacology (Berl). 237
4-Methylcathinone
Psychedelic drug
6-EAPB, also known as 1-(benzofuran-6-yl)-N-ethylpropan-2-amine, is a potentially psychedelic and potentially entactogenic drug of the benzofuran class;
6-EAPB
Pharmaceutical compound
2-APB, also known as 2-aminopropylbenzofuran, is a novel designer drug of the benzofuran family. Substituted benzofuran 2-MAPB Benzofuranylpropylaminopentane
2-APB_(entactogen)
Sympathomimetic nasal decongestant (Phenethylamine group)
and other phenethylamines. It is the N-methyl derivative of β-methylphenethylamine (BMPEA) and the β-methyl derivative of N-methylphenethylamine (NMPEA)
Phenpromethamine
Drug class
3,4-methylenedioxymethamphetamine (MDMA), 3,4-methylenedioxyamphetamine (MDA) and 3,4-methylenedioxyethylamphetamine (MDEA). ATS used illicitly often
Norepinephrine–dopamine releasing agent
Norepinephrine–dopamine_releasing_agent
Monoamine releaser and entactogen
BK-NM-AMT, or βk-NM-αMT, also known as β-keto-N-methyl-αMT or α,N-dimethyl-β-ketotryptamine, as well as 3-indoylmethcathinone, is a serotonin–dopamine
BK-NM-AMT
Pharmaceutical compound
effective biochemically, is not of as long a duration of action. The N-methyl homolog of 4-bromo-phenylisopropylamine has demanded interest from a separate
Para-Bromomethamphetamine
Pharmaceutical compound
of the amphetamine and benzothiophene families. It is related to MDA and other MDA bioisosteres like the benzofurans. The drug acts as a potent and well-balanced
6-APBT
Chemical compound of the cathinone class
methedrone, will be replaced. This will lead to a smaller compound. The methyl group bound to the oxygen at the benzene group will be replaced by an H-atom
Methedrone
Pharmaceutical compound
7-(2-Aminopropyl)benzofuran (7-APB) is a monoamine releasing agent and designer drug of the benzofuran family, albeit with a potency an order of magnitude
7-APB
Chemical compound
6-(2-Aminopropyl)tetralin (6-APT), also sometimes called tetralinylaminopropane (TAP), is a drug of the amphetamine class which acts as a selective serotonin
6-APT
Pharmaceutical compound
4-(2-Aminopropyl)benzofuran (4-APB) is a monoamine releasing agent and novel designer drug of the benzofuran family. It acts as a serotonin–norepinephrine–dopamine
4-APB
Designer stimulant
2-Fluoromethcathinone (2-FMC), also known as 2-flephedrone, is a psychostimulant and designer drug of the cathinone family. It acts as a dopamine and norepinephrine
2-Fluoromethcathinone
Pharmaceutical compound
Randall LO (1942). "Relative pharmacological effects of 1-methyl-3,4-dihydro-and 1-methyl-1,2,3,4-tetrahydroisoquinoline derivatives". The Journal of
4-Methoxyphenethylamine
Class of psychoactive drugs
substances include 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxy-N-ethylamphetamine (MDEA; "Eve"), N-methyl-1,3-benzodioxolylbutanamine (MBDB; "Eden")
Substituted methylenedioxyphenethylamine
Substituted_methylenedioxyphenethylamine
Chemical compound
heptaminol (2-methyl-6-amino-2-heptanol), iproheptine (N-isopropyl-1,5-dimethylhexylamine), isometheptene (2-methyl-6-methylamino-2-heptene), octodrine (2-amino-6-methylheptane
Methylhexanamine
Chemical compound
Phenethylamines: 2-Methyl-MDA pCPE 4-CAB 4-FA 4-FMA 4-HA 4-MTA 4-ME 5-APB 5-APBT 5-APDB 5-MAPB 5-Methyl-MDA 6-APB 6-APBT 6-APDB 6-MAPB 6-Methyl-MDA AEMMA Amiflamine
3-Chlorophenmetrazine
Chemical compound
Lophophine (MMDPEA) Amphetamines: 2-Methyl-MDA 3,4-MDA (tenamfetamine) 5-Methyl-MDA 6-Methyl-MDA d2-MDMA DFMDA EIDA Lys-MDA MDEA (MDE) MDMA (midomafetamine;
Ethylone
Pharmaceutical compound
Phenylbutynamine (4-phenylbut-3-yn-2-amine; development code PAL-874) is a monoamine releasing agent (MRA) of the arylalkylamine family related to β-phenethylamine
Phenylbutynamine
Chemical compound
1,3-Dimethylbutylamine (1,3-DMBA, dimethylbutylamine, DMBA, 4-amino-2-methylpentane, or AMP), is a stimulant drug structurally related to methylhexanamine
1,3-Dimethylbutylamine
Entactogen
known as 5-(2-aminopropyl)benzofuran, is a phenethylamine, amphetamine, and benzofuran and an analogue of 3,4-methylenedioxyamphetamine (MDA). 5-APB is
5-APB
Sympathomimetic agent
Name; brand names Heptin, Heptadrine, Tuamine; also known as tuamine and 2-aminoheptane) is a sympathomimetic agent and vasoconstrictor which is used
Tuaminoheptane
Chemical compound
approximately 2.3 hours after chewing khat leaves, the maximum concentration of cathinone in blood plasma is reached. The mean residence time is 5.2 ± 3.4 hours
Cathinone
Chemical compound
DFMDA, also known as F2-MDA or as 3,4-(difluoromethylenedioxy)amphetamine, is a chemical compound of the phenethylamine, amphetamine, and MDxx families
DFMDA
Pharmaceutical compound
Phenethylamines: 2-Methyl-MDA pCPE 4-CAB 4-FA 4-FMA 4-HA 4-MTA 4-ME 5-APB 5-APBT 5-APDB 5-MAPB 5-Methyl-MDA 6-APB 6-APBT 6-APDB 6-MAPB 6-Methyl-MDA AEMMA Amiflamine
3-Chloro-N-cyclopropylcathinone
3-Chloro-N-cyclopropylcathinone
Pharmaceutical compound
Company's patented novel MDXX molecule. [...] APA-01 is (R)-2-[(2H-1,3-benzodioxol-5-yl)methyl]pyrrolidine, a novel molecule protected by United States Patent
APA-01
Catecholaminergic type of drug
doi:10.3987/REV-06-SR(O)1. ISSN 0385-5414. Liu S, Molino BF (2007). "Chapter 2 Recent Developments in Monoamine Reuptake Inhibitors". Annual Reports in Medicinal
Norepinephrine releasing agent
Norepinephrine_releasing_agent
Designer stimulant drug
4-Methylbuphedrone (also known as 4-MeMABP, BZ-6378 and 4-Methyl-α-methylamino-butyrophenone), is a stimulant drug of the cathinone class that has been
4-Methylbuphedrone
Chemical compound
by-product. The amphetamine [300-62-9] (2) is then added and this is allowed to react overnight to give N-(1-phenyl-2-propylamine)-acetonitrile (3). Nitrosylation
Feprosidnine
Drug class
Predicting Drug-Induced Cardiotoxicity in Humans". Toxicological Sciences. 171 (2): 283–295. doi:10.1093/toxsci/kfz165. ISSN 1096-6080. PMC 6760275. PMID 31359052
Serotonin–norepinephrine releasing agent
Serotonin–norepinephrine_releasing_agent
Chemical compound
N-dimethyltryptamine (α,N-DMT; N-methyl-αMT), α,N,N-trimethyltryptamine (α,N,N-TMT; N-dimethyl-αMT), α-methylserotonin (α-methyl-5-HT; 5-hydroxy-αMT), and
Α-Methyltryptamine
Pharmaceutical compound
a methylamine-like side chain, is a potent MRA and psychostimulant. Homo-MDA Homo-MDMA Forsyth AN (22 May 2012). "Synthesis and Biological Evaluation
Phenylpropylamine
Class of chemical compounds
selected APBs 2-APB 3-APB 4-APB 5-APB 6-APB 7-APB Structural comparison of 5-APB and 6-APB with other related phenethylamines 5-APB 6-APB MDA 3-MA (MMA)
Substituted_benzofuran
Pharmaceutical compound
of the amphetamine and benzothiophene families. It is related to MDA and other MDA bioisosteres like the benzofurans. The drug acts as a potent
5-APBT
Stimulant designer drug of the substituted cathinone class
2-Methylmethcathinone (2-MMC), also known as ortomephedrone, is a recreational designer drug with stimulant and euphoric effects. It is a substituted cathinone
2-Methylmethcathinone
Adrenergic and dopaminergic cardiac stimulant
(1) and 2-nitropropane (2) to give 2-methyl-2-nitro-1-phenylpropan-1-ol (3). The nitro group is reduced with zinc in sulfuric acid giving 2-phenyl-1
Mephentermine
Type of drug
"Characterization of a novel and potentially lethal designer drug (±)-cis-para-methyl-4-methylaminorex (4,4'-DMAR, or 'Serotoni')". Drug Testing and Analysis
Dopamine_releasing_agent
Chemical compound
Lophophine (MMDPEA) Amphetamines: 2-Methyl-MDA 3,4-MDA (tenamfetamine) 5-Methyl-MDA 6-Methyl-MDA d2-MDMA DFMDA EIDA Lys-MDA MDEA (MDE) MDMA (midomafetamine;
5-MBPB
Decongestant and stimulant drug
propylhexedrine are the same as methamphetamine, all three molecules containing the 2-methylaminopropyl side-chain. The difference between them is that whereas
Cyclopentamine
Designer drug
Phenethylamines: 2-Methyl-MDA pCPE 4-CAB 4-FA 4-FMA 4-HA 4-MTA 4-ME 5-APB 5-APBT 5-APDB 5-MAPB 5-Methyl-MDA 6-APB 6-APBT 6-APDB 6-MAPB 6-Methyl-MDA AEMMA Amiflamine
Metaphedrine
Pharmaceutical compound
6-MAPBT, also known as 6-(2-(methylamino)propyl)-1-benzothiophene, is a possible entactogen of the phenethylamine, amphetamine, and benzothiophene families
6-MAPBT
Stimulant drug
Phenethylamines: 2-Methyl-MDA pCPE 4-CAB 4-FA 4-FMA 4-HA 4-MTA 4-ME 5-APB 5-APBT 5-APDB 5-MAPB 5-Methyl-MDA 6-APB 6-APBT 6-APDB 6-MAPB 6-Methyl-MDA AEMMA Amiflamine
Metamfepramone
Phenethylamine derivative
2-Aminoacetophenone, also known as β-ketophenethylamine, α-desmethylcathinone, or phenacylamine, is a substituted phenethylamine derivative. It is the
2-Aminoacetophenone
Class of compounds
4-Methylthioamphetamine (4-MTA) 2-Methyl-3,4-methylenedioxyamphetamine (2-Methyl-MDA) 3-Methyl-4,5-methylenedioxyamphetamine (5-Methyl-MDA) 3,4-Ethylenedioxy-N-methylamphetamine
Serotonin_releasing_agent
Pharmaceutical compound
2-amine". PubChem. U.S. National Library of Medicine. Retrieved 23 October 2024. "1-(1,3-benzoxathiol-5-yl)-N,N-dimethylpropan-2-amine". PubChem
MYCO-007
Pharmaceutical compound
than racemic MDMA. ALA-002 is in phase 2 clinical trials for SAD and ASD as of 2026, whereas AM-1002 is in phase 1/2 trials for GAD as of 2026. Jupiter Neurosciences
Non-racemic_MDMA
travel, tourism, insurance
2 METHYL-MDA
2 METHYL-MDA
2 METHYL-MDA
2 METHYL-MDA
2 METHYL-MDA
2 METHYL-MDA
2 METHYL-MDA
2 METHYL-MDA
2 METHYL-MDA
travel, tourism, insurance